BD Ultra-Fine Insulin Syringe Recall Due to Nonsterile Manufacturing
Becton Dickinson is recalling 45,000 units of BD Ultra-Fine Insulin Syringes (catalog 326679, lot 2164338) due to nonsterile manufacturing that could expose patients to pathogenic microorganisms and local infection. Distribution was worldwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall involves a nonsterile medical device with potential exposure to pathogenic microorganisms. The source text indicates a risk of local infection but does not report any illnesses or injuries, making this a theoretical risk-of-harm scenario that meets the threshold for a High severity rating.
Plain-English summary
Becton Dickinson & Company is recalling 45,000 units of BD Ultra-Fine Insulin Syringes (0.5mL, 6mm, 31G, catalog number 326679) due to a manufacturing defect. The affected products are lot number 2164338 with an expiration date of August 31, 2027. These syringes are medical devices designed to administer insulin for the treatment of diabetes mellitus.
The recall was initiated because the syringes were manufactured nonsterile. Nonsterile syringes create a potential for patients to be exposed to pathogenic microorganisms, which poses a risk of local infection at the injection site.
The affected syringes were distributed worldwide, including throughout the United States and in the following countries: Chile, Colombia, Dominican Republic, Bahamas, Panama, Peru, Mexico, El Salvador, Malaysia, Philippines, Vietnam, Hong Kong, Taiwan, Thailand, and Canada.
The recalled product
- Product
- BD Ultra-Fine Insulin Syringe 0.5mL, 6mm, 31G - Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 326679
- Manufacturer
- Becton Dickinson & Company
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- UDI_DI: N/A Lot Number: 2164338 Exp Date: 20270831
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 8 recalled by Becton Dickinson & Company under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 8 products in this recall →Related recalls
Same manufacturer · Becton Dickinson & Company
See all →- SevereBD Whitacre 24 gauge spinal trays recalled over bupivacaine quality issues
FDA (Devices) · 2026-06-10
- SevereBD combined Whitacre and Quincke spinal trays recalled over bupivacaine
FDA (Devices) · 2026-06-10
- SevereBD Quincke spinal trays recalled over Huons bupivacaine quality issues
FDA (Devices) · 2026-06-10
- SevereBD Whitacre spinal trays across nine catalog numbers recalled over bupivacaine
FDA (Devices) · 2026-06-10
- SevereBD Whitacre 22G spinal trays recalled in Huons bupivacaine sub-recall
FDA (Devices) · 2026-06-10
Same hazard · nonsterile
See all →- HighBD Ultra-Fine Insulin Syringes Recalled Due to Nonsterile Condition
FDA (Devices) · 2023-03-22
- HighBD Insulin Syringes Recalled for Sterility Defect
FDA (Devices) · 2023-03-22
- HighBD Insulin Syringes Recalled for Nonsterile Condition and Infection Risk
FDA (Devices) · 2023-03-22
- HighBD Ultra-Fine Insulin Syringe 0.5mL Recalled for Nonsterility Risk
FDA (Devices) · 2023-03-22
- HighBD Insulin Syringes Recalled Due to Nonsterile Condition
FDA (Devices) · 2023-03-22